Cart
sales@molnova.com
TRPM8 antagonist 3
CAS No. 2102179-29-1
TRPM8 antagonist 3( —— )
Catalog No. M28848 CAS No. 2102179-29-1
TRPM8 antagonist 3 is a blocker of TRPM8 (IC50 = 11 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 86 | In Stock |
|
| 5MG | 78 | In Stock |
|
| 10MG | 122 | In Stock |
|
| 25MG | 201 | In Stock |
|
| 50MG | 287 | In Stock |
|
| 100MG | 405 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTRPM8 antagonist 3
-
NoteResearch use only, not for human use.
-
Brief DescriptionTRPM8 antagonist 3 is a blocker of TRPM8 (IC50 = 11 nM).
-
DescriptionTRPM8 antagonist 3 is a blocker of TRPM8 (IC50 = 11 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorD3 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2102179-29-1
-
Formula Weight292.315
-
Molecular FormulaC13H12N2O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (85.53 mM)
-
SMILESO=C(C1=C(O)N=C(C2=CC=CC=C2O)S1)N3OCCC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Grundt P, et al. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. J Med Chem. 2005 Feb 10;48(3):839-48.
molnova catalog
related products
-
M8-B Hydrochloride
M8-B Hydrochloride is a selective transient receptor potential melastatin-8 (TRPM8) channel antagonist.M8 B, a TRPM8 antagonist.
-
Supercinnamaldehyde
Supercinnamaldehyde is a transient receptor potential anchor protein 1 (TRPA1) activator with thousands of anticancer and antimicrobial activities.
-
A 425619
A 425619 is a potent TRPV1 antagonistsystemic administration of the TRPV1 antagonist, A-425619, reversed the decrease in digging behavior induced by CFA injection, further confirming the role of TRPV1, expressed by knee neurons, in acute inflammatory joint pain.
